A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms.
Uthaug, M. V., Lancelotta, R., van Oorsouw, K., Kuypers, K. P. C., Mason, N., Rak, J., ... & Páleníček, T. | Psychopharmacology | 13 April 2019
Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use
Luethi, D., Hoener, M. C., Krähenbühl, S., Liechti, M. E., & Duthaler, U. | Biochemical pharmacology | 11 April 2019
Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.
Baggott, M. J., Garrison, K. J., Coyle, J. R., Galloway, G. P., Barnes, A. J., Huestis, M. A., & Mendelson, J. E. | Journal of psychoactive drugs | 9 April 2019
Psychedelic-Assisted Group Therapy: A Systematic Review.
Trope, A., Anderson, B. T., Hooker, A. R., Glick, G., Stauffer, C., & Woolley, J. D. | Journal of Psychoactive Drugs | 5 April 2019
Receptor-Enriched Analysis of functional connectivity by targets (REACT): A novel, multimodal analytical approach informed by PET to study the pharmacodynamic response of the brain under MDMA
Dipasquale, O., Selvaggi, P., Veronese, M., Gabay, A. S., Turkheimer, F., Mehta, M. A. | NeuroImage | 4 April 2019
Oxytocin-dependent reopening of a social reward learning critical period with MDMA
Nardou, R., Lewis, E. M., Rothhaas, R., Xu, R., Yang, A., Boyden, E., & Dölen, G. | Nature | 3 April 2019
Classic psychedelics: the special role of the visual system
Császár-Nagy, N., Kapócs, G., & Bókkon, I. | Reviews in the neurosciences | 2 April 2019
Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration.
Fadiman, J., & Korb, S. | Journal of psychoactive drugs | 29 March 2019
Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).
Curry, D. W., Berro, L. F., Belkoff, A. R., Sulima, A., Rice, K. C., & Howell, L. L. | Neuropharmacology | 25 March 2019
Embracing Neurodiversity in Psychedelic Science: A Mixed-Methods Inquiry into the MDMA Experiences of Autistic Adults
Danforth, A. L. | Journal of psychoactive drugs | 25 Mar 2019
Salvia divinorum: from recreational hallucinogenic use to analgesic and anti-inflammatory action
Coffeen, U., & Pellicer, F. | Journal of pain research | 22 March 2019
A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy.
Sessa, B., Higbed, L., & Nutt, D. | Frontiers in Psychiatry | 20 March 2019
Combining Cognitive-Behavioral Conjoint Therapy for PTSD with 3,4-Methylenedioxymethamphetamine (MDMA): A Case Example.
Wagner, A. C., Mithoefer, M. C., Mithoefer, A. T., & Monson, C. M. | Journal of psychoactive drugs | 19 March 2019
Ketamine: A Paradigm Shift for Depression Research and Treatment
Krystal, J. H., Abdallah, C. G., Sanacora, G., Charney, D. S., & Duman, R. S. | Neuron | 6 March 2019
Beyond LSD: A Broader Psychedelic Zeitgeist during the Early to Mid-20th Century.
Aday, J. S., Bloesch, E. K., & Davoli, C. C. | Journal of psychoactive drugs | 6 March 2019
Ibogaine Administration Modifies GDNF and BDNF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits.
Marton, S., González, B., Rodríguez, S., Miquel, E., Martínez-Palma, L., Pazos, M., ... & Scorza, C. | Frontiers in pharmacology | 5 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N, N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents.
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019
Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
Cameron, L. P., Benson, C. J., DeFelice, B. C., Fiehn, O., & Olson, D. E. | ACS chemical neuroscience | 4 March 2019
5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety
Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019
Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care.
Dyck, E. | Journal of psychoactive drugs | 1 March 2019
Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers
Erritzoe, D., Smith, J., Fisher, P. M., Carhart-Harris, R., Frokjaer, V. G., & Knudsen, G. M.| Journal of Psychopharmacology | 28 February 2019
Sub-Acute Effects of Psilocybin on Empathy, Creative Thinking, and Subjective Well-Being
Mason, N. L., Mischler, E., Uthaug, M. V., Kuypers, K. P. | Journal of psychoactive drugs | 26 Feb 2019
Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder
Zheng, W., Zhou, Y. L., Liu, W. J., Wang, C. Y., Zhan, Y. N., Li, H. Q., & Ning, Y. P. | Journal of Psychopharmacology | 21 February 2019